📰 Complete Response News
Page 10 - Complete Response News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Complete Response. Real-time updates on events, politics, business and more.
February 16, 2022
FDA committees voted 8 yes, 14 no on whether the data provided to support the benefits of IV tramadol outweigh the risks for the management of acute pain.
February 8, 2022
/PRNewswire/ - enGene Inc., a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal tissues...
February 8, 2022
/PRNewswire/ - enGene Inc., a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal tissues...
February 3, 2022
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced financial results for the fourth quarter and full year of 2021 today. "Lilly had a remarkable year...
December 27, 2021
/PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next generation antibody therapeutics,...
December 23, 2021
Here's a roundup of top developments in the biotech space this week. Allakos’s Lirentelimab Flunks Late-Stage Studies in ...
December 16, 2021
QBiotics commences the Australian commercial launch of its lead veterinary drug, STELFONTA®, which is approved by the Australian Pesticides and...
December 14, 2021
/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
December 14, 2021
/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
December 13, 2021
/PRNewswire/ -- Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of...